Europe Pharmaceutical Cold Chain Logistics Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 19.59 Billion |
| Market Size (2029) | USD 31.32 Billion |
| CAGR (2024 - 2029) | 10.00 % |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Europe Pharmaceutical Cold Chain Logistics Market Analysis
The Europe Pharmaceutical Cold Chain Logistics Market size is estimated at USD 19.59 billion in 2024, and is expected to reach USD 31.32 billion by 2029, growing at a CAGR of 10% during the forecast period (2024-2029).
Europe is home to some of the largest pharmaceutical and life sciences companies, including Roche Holding (Switzerland), Sanofi (France), GlaxoSmithKline (United Kingdom), AstraZeneca (United Kingdom), Novo Nordisk (Denmark), Merck Group (Germany), Allergan (Ireland), UCB (Belgium), Ipsen (France), and Lundbeck (Denmark), among others. Several pharmaceutical and life sciences companies are investing in Europe owing to the potential and opportunities it provides. Companies have been getting into M&As, opening manufacturing plants, investing in warehouses, technology advancements, etc., to expand their product offerings and improve their market share.
Owing to the large pharmaceutical market, Europe is one of the largest importers and exporters of pharmaceuticals. The United States and Switzerland were the EU's main trading partners for medicinal products in 2020. Among the EU member states, Germany was the largest exporter (EUR 49 billion) of medicinal products in 2020. The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents around 1,900 pharmaceutical companies operating in Europe.
National pharmaceutical industry associations in the following 33 European countries are members of EFPIA: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, the Netherlands, Norway, Poland, Portugal, Romania, the Russian Federation, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, and the United Kingdom. In addition, 40 leading pharmaceutical companies are EFPIA members. COVID-19 further accelerated the demand for drugs and vaccines across Europe, which, in turn, drove the growth of the pharmaceutical logistics market in Europe.
Europe Pharmaceutical Cold Chain Logistics Market Trends
Growing European Pharmaceutical Industry
- Europe is the second-largest biopharmaceuticals market in the world. The increasing population and chronic diseases are propelling the growth of the market studied. The adoption and accessibility, availability of biopharmaceuticals for the treatment and diagnosis of diseases, and awareness related to medicine raised the European market. Western Europe contains more than 33% of manufacturing facilities worldwide. Biopharma products have higher efficiency with safety than other products.
- In the European Union, about 80% of pharma products now require temperature-controlled transportation. For years, pharmaceutical mandates in most countries required products to be maintained within manufacturer-established guidelines only in storage. However, the European Union issued guidelines on Good Distribution Practices for medicinal products for human use, extending temperature requirements to transportation and expanding coverage to include over-the-counter drugs.
- To fulfill such needs, several warehouses comprising cold chain systems are designed to ensure the ideal storage and transportation conditions for temperature-sensitive products. Moreover, businesses invest millions of dollars in their cold chain operations to create effective, efficient, and reliable processes, as end-to-end cold chain security is the weak link in the system.
- In addition, temperature-controlled logistics of pharmaceutical products and medical devices is a significantly growing part of the healthcare logistics industry. Further, the development of complex biological-based medicines and shipment of hormone treatments, vaccines, and complex proteins that require cold chain refinements result in the need for temperature-controlled transportation and warehousing. In addition, an increase in the need for effective cold chain logistics services to maintain the quality of goods fuels the growth of the market studied.
Increased Demand for Cold Chain Logistics Market
- As more and more people move to cities, there is a growing demand for fresh and prepared foods, which need to be transported and stored in a refrigerated environment; the e-commerce sales of food and beverages are growing rapidly in Europe, and this is driving demand for cold chain logistics to deliver these products to consumers doorsteps.
- In addition to these factors, the COVID-19 pandemic also highlighted the importance of cold chain logistics for the safe and efficient distribution of essential goods, such as food and medicine.
- Investors are building new cold storage facilities in strategic locations across Europe to meet the demand for temperature-controlled storage capacity. For example, in March 2023, Lineage Logistics announced the acquisition of a new facility in Belgium to expand its presence in the European market. Investors are also investing in transportation infrastructure to improve the efficiency and reliability of cold-chain transportation. For instance, in 2022, Maersk announced the launch of a new reefer container service that provides end-to-end visibility and control for the transportation of temperature-sensitive goods.
Europe Pharmaceutical Cold Chain Logistics Industry Overview
The European pharmaceutical logistics market is relatively fragmented, with prominent regional, global, and small- and medium-sized local players. The market is dominated by a few international players, such as DHL, FedEx, Kuehne + Nagel International AG, United Parcel Service, and CH Robinson. Some of the major domestic players include Eurotranspharma, Centre Spécialités Pharmaceutiques, PostNL Pharma & Care, and Trans-o-Flex Schnell-Lieferdienst GmbH. The growing demand for temperature-controlled products and refrigerated packaging solutions to maintain the quality of pharma products has enabled the logistics players to diversify their service portfolio and gain more profit.
Europe Pharmaceutical Cold Chain Logistics Market Leaders
-
DHL Supply Chain
-
FedEx Corporation
-
C.H Robinson Worldwide Inc
-
Kuehne + Nagel AG
-
DB Schenker
*Disclaimer: Major Players sorted in no particular order
Europe Pharmaceutical Cold Chain Logistics Market News
- September 2023: DHL Supply Chain has opened a new, third logistics center at its Life Sciences & Healthcare (LSH) Campus in Florstadt, Germany. The new 32,000 square meter center is within walking distance of both the existing warehouse and a second site that opened in January 2018. The new center is climate-neutral and holds all major certifications for the healthcare industry.
- October 2023: Kuehne +Nagel AG announced the launch of its new pharmaceutical cold chain logistics facility in Amsterdam, the Netherlands. The facility is located in the heart of the Amsterdam Airport Schiphol Logistics Park, making it a strategic location for the import and export of pharmaceuticals.
Europe Pharmaceutical Cold Chain LogisticsMarket Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions
1.2 Market Definition
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1 Current Market Scenario
4.2 Industry Supply Chain/Value Chain Analysis
4.3 Technological Trends
4.4 Government Regulations and Initiatives
4.5 Investment Scenario
4.6 Spotlight on Europe 3PL Market
4.7 Impact of Covid-19 on the Market
5. MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Demand for Healthcare Services
5.1.2 Stringent Regulations and Quality Standards
5.1.3 Growing E-Commerce Market
5.2 Market Restraints
5.2.1 Cold Chain Management
5.2.2 Product Counterfieting
5.3 Market Opportunities
5.3.1 Technological Adavancements
5.3.2 Outsourcing Opportunities
5.3.3 Sustainability and Environmental Concerns
5.4 Porter's Five Forces Analysis
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Buyers/Consumers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitute Products
5.4.5 Intensity of Competitive Rivalry
6. MARKET SEGMENTATION
6.1 By Product
6.1.1 Generic Drugs
6.1.2 Branded Drugs
6.2 By Application
6.2.1 Bio-Pharma
6.2.2 Chemical Pharma
6.3 By Mode of Transport
6.3.1 Air Shipping
6.3.2 Rail Shipping
6.3.3 Road Shipping
6.3.4 Sea Shipping
6.4 By Country
6.4.1 Germany
6.4.2 United Kingdom
6.4.3 Netherlands
6.4.4 France
6.4.5 Italy
6.4.6 Spain
6.4.7 Poland
6.4.8 Belgium
6.4.9 Sweden
6.4.10 Rest of Europe
7. COMPETITIVE LANDSCAPE
7.1 Market Concentration Overview
7.2 Major Players
7.2.1 DHL Supply Chain
7.2.2 FedEx Corporation
7.2.3 Kuehne + Nagel International AG
7.2.4 United Parcel Service Inc.
7.2.5 C.H Robinson Worldwide Inc.
7.2.6 CEVA Logistics
7.2.7 DB Schenker
7.2.8 Agility Logistics
7.2.9 EuroTrans Pharma
7.2.10 CSP
7.2.11 Trans-o-flex GmbH
7.2.12 PostNL Pharma & Care
7.2.13 Astra Logistic Ltd.
8. FUTURE OUTLOOK OF THE MARKET
9. APPENDIX
9.1 Macroeconomic Indicators (gdp Distribution, By Activity)
9.2 Trade Statistics - Imports And Exports Statistics
10. CREDENTIALS
11. ABOUT US
Europe Pharmaceutical Cold Chain Logistics Industry Segmentation
Pharmaceutical logistics is related to the handling, transport, and chain management of multiple and varied products, the vast majority of which require specific conditions in their logistic treatment.
The European pharmaceutical cold chain logistics market is segmented by product (generic drugs, branded drugs), by application (bio-pharma, chemical pharma), by mode of transport (air shipping, rail shipping, road shipping, and sea shipping), by country (Germany, United Kingdom, Netherlands, France, Italy, Spain, Poland, Belgium, Sweden, and Rest of Europe).
The report offers the market sizes and forecasts for the European pharmaceutical cold chain logistics market in value (USD) for all the above segments.
| By Product | |
| Generic Drugs | |
| Branded Drugs |
| By Application | |
| Bio-Pharma | |
| Chemical Pharma |
| By Mode of Transport | |
| Air Shipping | |
| Rail Shipping | |
| Road Shipping | |
| Sea Shipping |
| By Country | |
| Germany | |
| United Kingdom | |
| Netherlands | |
| France | |
| Italy | |
| Spain | |
| Poland | |
| Belgium | |
| Sweden | |
| Rest of Europe |
Europe Pharmaceutical Cold Chain LogisticsMarket Research FAQs
How big is the Europe Pharmaceutical Cold Chain Logistics Market?
The Europe Pharmaceutical Cold Chain Logistics Market size is expected to reach USD 19.59 billion in 2024 and grow at a CAGR of 10% to reach USD 31.32 billion by 2029.
What is the current Europe Pharmaceutical Cold Chain Logistics Market size?
In 2024, the Europe Pharmaceutical Cold Chain Logistics Market size is expected to reach USD 19.59 billion.
Who are the key players in Europe Pharmaceutical Cold Chain Logistics Market?
DHL Supply Chain, FedEx Corporation, C.H Robinson Worldwide Inc, Kuehne + Nagel AG and DB Schenker are the major companies operating in the Europe Pharmaceutical Cold Chain Logistics Market.
What years does this Europe Pharmaceutical Cold Chain Logistics Market cover, and what was the market size in 2023?
In 2023, the Europe Pharmaceutical Cold Chain Logistics Market size was estimated at USD 17.81 billion. The report covers the Europe Pharmaceutical Cold Chain Logistics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Pharmaceutical Cold Chain Logistics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Europe Pharmaceutical Cold Chain LogisticsIndustry Report
Statistics for the 2024 Europe Pharmaceutical Cold Chain Logistics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Pharmaceutical Cold Chain Logistics analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
